Table 2. Results of univariable and multivariable analyses of factors associated with the presence of sarcopenia in lung cancer patients.
Univariable odds ratio (95% CI) | p value | Multivariable odds ratio (95% CI) | p value | |
---|---|---|---|---|
Age, years | ||||
Non-elderly | 1.00 (reference) | 1.00 (reference) | ||
Elderly (≥ 65yrs) | 2.05 (1.52–2.77) | <0.001 | 2.02 (1.39–2.93) | < 0.001 |
Gender | ||||
Female | 1.00 (reference) | 1.00 (reference) | ||
Male | 8.34 (5.56–12.68) | < 0.001 | 11.13 (6.05–20.47) | < 0.001 |
Cancer types | ||||
Adenocarcinoma | 1.00 (reference) | 1.00 (reference) | ||
Squamous cell carcinoma | 1.89 (1.32–2.70) | < 0.001 | 0.93 (0.59–1.47) | 0.761 |
Small cell lung cancer | 2.01 (1.34–3.01) | 0.001 | 1.10 (0.66–1.84) | 0.711 |
Others¶ | 1.86 (1.21–2.87) | 0.005 | 1.06 (0.62–1.82) | 0.827 |
Cancer Stage (TNM) | ||||
I | 1.00 (reference) | 1.00 (reference) | ||
II | 1.64 (0.93–2.87) | 0.086 | 0.90 (0.46–1.79) | 0.770 |
III | 2.25 (1.40–3.61) | 0.001 | 1.40 (0.79–2.49) | 0.250 |
IV | 2.86 (1.87–4.37) | < 0.001 | 1.98 (1.16–3.37) | 0.012 |
Charlson comorbidity index | ||||
0–2 | 1.00 (reference) | 1.00 (reference) | ||
≥3 | 1.51 (1.01–2.25) | 0.043 | 1.93 (1.19–3.13) | 0.008 |
Body mass index (kg/m2) | ||||
≥ 23 | 1.00 (reference) | 1.00 (reference) | ||
< 23 | 4.78 (3.52–6.48) | < 0.001 | 6.28 (4.37–9.02) | < 0.001 |
Smoking history | ||||
Never-smoker | 1.00 (reference) | 1.00 (reference) | ||
Current or ex-smoker | 4.41 (3.06–6.35) | < 0.001 | 1.00 (0.56–1.80) | 0.995 |